Form 4: Appian Corp: CEO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Appian Corp's CEO, Matthew Calkins, has sold a significant number of Class A Common Stock shares as part of a pre-arranged trading plan.
Summary
- Matthew Calkins, CEO and President of Appian Corp, sold shares of Class A Common Stock on July 7, 2026.
- These sales were executed automatically under a Rule 10b5-1 trading plan adopted on March 5, 2026.
- A total of 37,515 shares were sold at a weighted average price of $24.61.
- An additional 12,485 shares were sold at a weighted average price of $25.07.
- Following these transactions, Calkins beneficially owns 1,731,629 shares directly.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a neutral to slightly negative sentiment due to the significant sale of shares by the CEO, despite the transaction being conducted under a Rule 10b5-1 plan.
Negatives
- CEO Matthew Calkins sold a total of 50,000 shares of Class A Common Stock.
- The sales occurred at prices between $23.87 and $25.24, indicating a disposition of company stock by a key executive.
Risks
- The sale of a substantial number of shares by the CEO, even under a 10b5-1 plan, could be interpreted negatively by the market, potentially impacting investor sentiment.
- While the plan was established in March 2026, the execution in July 2026 might coincide with market conditions or company performance that could lead to scrutiny of the timing.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it solely reports on past transactions.
Industry Context
StockSavvy.ai notes that insider selling, even under a pre-arranged plan like a Rule 10b5-1, can sometimes be a signal that investors watch closely, though the existence of the plan mitigates concerns about opportunistic trading.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Rule 10b5-1 Trading Plan | Matthew Calkins executed sales of Class A Common Stock under a pre-established Rule 10b5-1 trading plan. | 03/05/2026 | This plan allows insiders to sell stock at predetermined times or prices, providing an affirmative defense against allegations of insider trading. It demonstrates adherence to established governance procedures for managing insider stock sales. |
Stakeholder Impact
- Shareholders: May view the CEO's stock sale with caution, potentially leading to short-term price pressure, although the 10b5-1 plan mitigates concerns about insider trading.
- Employees: May be influenced by the CEO's stock disposition, potentially affecting morale or their own investment decisions.
- Management: The sale by the CEO could be seen as a personal financial decision unrelated to company performance, but it is still a notable event.
Next Steps
- Continue to monitor future filings for any additional insider transactions or disclosures from Appian Corp.
Key Dates
| Date | Description |
|---|---|
| 03/05/2026 | Date Rule 10b5-1 trading plan was adopted by Matthew Calkins. |
| 07/07/2026 | Date of transactions (sales of Class A Common Stock). |
| 07/08/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe filing indicates a significant sale of stock by the CEO under a Rule 10b5-1 plan. While this plan is designed to avoid insider trading concerns, the sale itself by a key executive can be a signal that warrants caution. Without further context on the company's performance or the reasons for the sale, a 'hold' recommendation is prudent, suggesting investors monitor the situation rather than making immediate buy or sell decisions.
Keywords
Appian Corp, APPN, Form 4, Insider Trading, Matthew Calkins, Stock Sale, Rule 10b5-1, Class A Common Stock, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.